Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritisanti-TNF


Creative Commons License

Duran E., Yildirim B. E. S., KARADAĞ Ö.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.5, sa.9, 2019 (SCI-Expanded, Scopus)